Impaired insulin sensitivity is thought to play an important role in the development of hyperinsulinemia and the progression of atherosclerotic-related conditions including hypertension, dysmetabolism, inflammation, endothelial dysfunction, and coronary artery disease (CAD), even among individuals without T2DM, or in the absence of any other clinical signs of insulin resistance. Here, INS is linked to Insulin resistance.